Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Morton

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The New England Journal of Medicine|June 10, 2026
Carbocisteine or Hypertonic Saline for Acute Respiratory FailureBronwen Connolly, Naomi Dickson, Christina Campbell, et al.
The Journal of Infectious Diseases|July 10, 2024
Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge ModelBridgette Galafa, Tarsizio Chikaonda, Evaristar Kudowa, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Plos One|July 1, 2025
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocolSanjita Brito-Mutunayagam, David O Hamilton, Elena Mitsi, et al.
The Lancet. Microbe|May 11, 2026
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trialAnthony E Chirwa, Evaristar Kudowa, Godwin Tembo, et al.
Cell Reports|May 26, 2026
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional studyJesús Reiné, Lisa A King, Youvika Singh, et al.
The Journal of Infection|June 4, 2026
Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United KingdomEmma C Carter, Cristina Fernandez, Charlotte Lim, et al.
Nature Medicine|November 20, 2024
Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian populationJames Nyirenda, Olympia M Hardy, João Da Silva Filho, et al.
International Journal of Epidemiology|February 28, 2023
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, et al.
PLOS Global Public Health|July 30, 2024
Interdisciplinary perspectives on multimorbidity in Africa: Developing an expanded conceptual modelJustin Dixon, Ben Morton, Misheck J Nkhata, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The New England Journal of Medicine|June 10, 2026
Carbocisteine or Hypertonic Saline for Acute Respiratory FailureBronwen Connolly, Naomi Dickson, Christina Campbell, et al.
The Journal of Infectious Diseases|July 10, 2024
Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge ModelBridgette Galafa, Tarsizio Chikaonda, Evaristar Kudowa, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Plos One|July 1, 2025
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocolSanjita Brito-Mutunayagam, David O Hamilton, Elena Mitsi, et al.
The Lancet. Microbe|May 11, 2026
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trialAnthony E Chirwa, Evaristar Kudowa, Godwin Tembo, et al.
Cell Reports|May 26, 2026
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional studyJesús Reiné, Lisa A King, Youvika Singh, et al.
The Journal of Infection|June 4, 2026
Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United KingdomEmma C Carter, Cristina Fernandez, Charlotte Lim, et al.
Nature Medicine|November 20, 2024
Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian populationJames Nyirenda, Olympia M Hardy, João Da Silva Filho, et al.
International Journal of Epidemiology|February 28, 2023
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, et al.
PLOS Global Public Health|July 30, 2024
Interdisciplinary perspectives on multimorbidity in Africa: Developing an expanded conceptual modelJustin Dixon, Ben Morton, Misheck J Nkhata, et al.
Pageof 6